comlogo01.svg comlogo01.svg

f4banner1.jpg f4bannerph1.jpg

Partnering

At Full-Life we are passionate about discovering, developing and delivering life-changing radiotherapeutics to cancer patients world wide. With our goal to provide new therapies to people with unmet medical need, we are seeking strategic partnerships with leading biopharma innovators to support us on our mission.

Business Development

  • f4img1.jpg
    Our Partnering Focus

    Strategic collaborations surrounding our pipeline of innovative RDC programs

    Platform discovery partnerships leveraging our Clear-X & Res-X technologies

    In-licensing opportunities to complement our in-house pipeline

  • f4img11.jpg
    Our Preferred Partners

    Bring complementary capabilities to jointly advance our assets through development towards commercialization

    Have a vision for maximizing value of our assets

    Recognize our expertise in clinical trial execution, RDC manufacturing & logistics to jointly bring innovative medicines to patients

f4imgpc14-7.jpg f4imgpg1.jpg
Click

Holistic Approach

To enhance our long-term strategy and maximize our company's asset value, our corporate and business development team systematically evaluates collaboration opportunities with diverse global and regional stakeholders in the biopharmaceutical and biotech industries.

Contact Us

If you are interested in joining forces with Full-Life, please contact us at BD@t-full.com

Read More
3654.png

Julie Wu

President & Chief Financial Officer

Julie is a seasoned pharmaceutical strategy and business development executive with a wealth of experience in the U.S. and China in investment banking, business development, and strategic planning, as well as business operations. Prior to Full-Life, she worked with numerous pharmaceutical companies, including Eli Lilly, Abbott, and Novartis, as well as with Citibank. Julie received her MBA degree in Finance from the Wharton School of the University of Pennsylvania.